MentalHealthDaily

Neuromodulation Therapies to Treat Neuroinflammation in Anxiety & Depression (2023 Research)

The intersection of neuromodulation, neuroinflammation, and their roles in mood disorders like anxiety and depression represents a significant stride in mental health research. This complex interplay underscores the potential of novel therapeutic strategies targeting the brain’s inflammatory pathways, offering new hope for effective management of these pervasive conditions. Highlights: Link Between Neuroinflammation and Mood Disorders: …

Medical Cannabis for Generalized Anxiety Disorders & Sleep Disturbances (2023 Study)

by GLOOM

Recent research has shed light on the potential benefits of cannabis-based medicinal products (CBMPs) in treating Generalized Anxiety Disorder (GAD), especially in patients with sleep disturbances. Recent research explored the effectiveness of CBMPs on GAD, the role of sleep quality in treatment outcomes, and the incidence of adverse events. Highlights: CBMPs Show Promise in Treating …

2 Gene Clusters & Anxiety Disorder Subtypes: Glutamate vs. Serotonin & Dopamine (2023 Study)

by GLOOM

Anxiety disorders (ADs) are a complex set of mental health conditions affecting millions globally. Recent research has made significant strides in understanding the genetic underpinnings of these disorders, linking them to specific brain regions and developmental stages. Highlights: Two Distinct Gene Clusters Identified: Researchers identified two gene clusters with distinct spatial expression profiles in the …

Unspecified Anxiety Disorder: Expert Treatment Recommendations in Japan (2023)

by GLOOM

Anxiety disorders, a widespread mental health concern, encompass a range of conditions, each with specific characteristics and treatment protocols. However, the realm of “unspecified anxiety disorder” remains a grey area, often challenging healthcare professionals due to its lack of clear-cut guidelines. A recent study aimed to fill this gap by developing a consensus among experts …

Gray Matter Abnormalities in Major Depression & Social Anxiety (2023 Analysis)

by GLOOM

Major depressive disorder (MDD) and social anxiety disorder (SAD) are two of the most prevalent mental health issues facing society today. They often occur together, challenging both patients and healthcare providers. Recent neuroimaging studies have begun to shed light on the unique and overlapping characteristics of these disorders, offering new insights into their complex neurobiology. …

Gut Microbiome & Social Anxiety Disorder: Abnormal Bacterial Composition (2023 Study)

by GLOOM

Recent scientific endeavors have unveiled a fascinating link between our gut microbiome and mental health, with a focus on Social Anxiety Disorder (SAD). This complex relationship, highlighting the role of microbial inhabitants in our gut in influencing our brain and behavior, marks a significant shift in understanding mental disorders. Highlights: Social Anxiety Disorder (SAD) affects …

Fatty Acid Sensor GPR120 (FFAR4) Treatment Target for Anxiety & Neuroinflammation (2023 Study)

by GLOOM

In the quest to understand the intricate relationship between our diet, brain, and behavior, scientists are turning their focus to a unique receptor, GPR120. This protein, known for interacting with long-chain fatty acids like omega-3s, is shedding new light on how our body’s inflammation and metabolism can directly affect our mental health. By exploring GPR120’s …